Dr McErlean’s research focuses on the design and development of cell penetrating peptide delivery systems for gene therapy targeting neurological diseases and for ex vivo adoptive cellular therapies. Her work brings together a unique combination of expertise in nanomedicine, drug delivery, biotechnology and biopharmaceuticals.

Open to PhD applications in the field of nano-drug delivery, biopharmaceutics, nucleic acid therapies and ex vivo cellular therapies.

• Development of nanomedicines for cancer and neurological diseases
• Design of non-viral delivery systems